导航差异和克服障碍,以获得糖尿病病治疗方法:一个拟议的多因素方法
Romela Petrosyan1, A Enrique Caballero2, Tracey L Henry3
1Division of Renal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Nephron
|November 13, 2025
概括
由于社会经济和临床因素,边缘化社区面临糖尿病病 (DKD) 治疗的重大障碍. 解决这些差异需要政策变化,改善医疗保健和患者教育,以获得公平的机会和更好的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 公共卫生 公共卫生
- 健康 公平 卫生 公平
背景情况:
- 糖尿病病 (DKD) 是一种严重的糖尿病并发症,不成比例地影响边缘化人口.
- 种族和民族少数群体,低社会经济地位和较低的教育水平尤其受到影响.
- 本综述探讨了这些群体内对DKD治疗的差异和获取障碍.
研究的目的:
- 探索DKD健康差异的根本原因.
- 确定阻碍边缘化社区获得DKD治疗的障碍.
- 提出可行的解决方案,以改善公平获取.
主要方法:
- 文献综述和现有关于DKD差异的研究综合.
- 分析导致不平等的社会经济,临床和患者相关因素.
- 检查当前和拟议的政策,临床和以患者为中心的干预措施.
主要成果:
- 社会经济因素 (保险,收入,识字) 和获得医疗保健的机会显著限制了治疗的机会.
- 临床问题包括认可不足,处方不足以及缺乏以患者为中心的护理.
- 患者因素包括意识低,坚持挑战和护理中断.
结论:
- 多方面的解决方案,包括政策改革 (例如,通货膨胀减缓法案),增强保险覆盖和基于价值的护理是必不可少的.
- 临床干预必须侧重于早期检测,诊断和管理.
- 患者教育和文化敏感的支持系统对于改善结果至关重要.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
331
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
Chronic Kidney Disease IV: Nursing Management
308
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
308
Chronic Kidney Disease I: Introduction
552
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552
Diabetes: Management and Pharmacotherapy
853
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
853
Chronic Kidney Disease II: Clinical Manifestations
537
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K


